🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to examine the effects of SB-480848 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08-26
Trial ID
NCT00734032
The purpose of this study is to compare the effects of SB-480848 with place...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00368576
Treatments Being Tested
The overall objective of this integrated analysis is to evaluate the clinic...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01636271
Treatments Being Tested
This study will determine the effect of single and repeat administration of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-19
Trial ID
NCT01873339
Treatments Being Tested
The purpose of this study is to determine any differences in pharmacokineti...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01154114
Treatments Being Tested
This will be an exploratory, open-label, single sequence, two part study (P...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-26
Trial ID
NCT02058641
Treatments Being Tested
Darapladib (SB-480848) is a novel, selective, orally active inhibitor of li...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-14
Trial ID
NCT01852565
Treatments Being Tested
The primary objective is to determine Lp-PLA2 activity in atherosclerotic c...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT01916720
Treatments Being Tested
IBIS-2 is a study using SB-480848 versus placebo in subjects with angiograp...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11-10
Trial ID
NCT00268996
Treatments Being Tested
In accordance with the recently revised FDA draft renal impairment guidance...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-29
Trial ID
NCT01711723
Treatments Being Tested